TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Semler Scientific ( (SMLR) ) has shared an announcement.
On September 22, 2025, Semler Scientific entered into a Merger Agreement with Strive, Inc., which will acquire Semler in an all-stock transaction. This merger positions Strive as the accounting acquirer, with Semler becoming a wholly-owned subsidiary, and is expected to bring strategic and financial benefits to the combined entity. The transaction, however, is subject to various risks and uncertainties, including potential volatility in Bitcoin, which is part of Semler’s treasury strategy, and the challenges of integrating the two companies.
The most recent analyst rating on (SMLR) stock is a Hold with a $27.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
Spark’s Take on SMLR Stock
According to Spark, TipRanks’ AI Analyst, SMLR is a Neutral.
The overall stock score of 57 reflects the company’s operational and cash flow challenges, despite a strong balance sheet and strategic initiatives in Bitcoin and healthcare. The technical analysis indicates a bearish trend, while the valuation suggests potential upside due to a low P/E ratio. The earnings call provided a mixed outlook, with significant achievements in Bitcoin but challenges in healthcare revenue and operating losses.
To see Spark’s full report on SMLR stock, click here.
More about Semler Scientific
Semler Scientific, Inc. operates in the healthcare industry, focusing on providing diagnostic and monitoring products and services. The company is known for its innovative solutions aimed at improving patient care and outcomes.
Average Trading Volume: 1,037,672
Technical Sentiment Signal: Sell
Current Market Cap: $389.6M
For a thorough assessment of SMLR stock, go to TipRanks’ Stock Analysis page.